Research Article
Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer
Figure 1
Antigen expression: the expression levels of the 15 vaccine antigens were examined by immunohistochemical staining in tumor tissues from nonvaccinated esophageal squamous cell carcinomas (). Representative results of immunohistochemical staining of 6 antigens are shown.